Bank Of America Corp Akebia Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.43 Trillion
Q3 2025

A detailed history of Bank Of America Corp transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,788,500 shares of AKBA stock, worth $3.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,788,500

Previous 1,110,480 61.06%

Holding current value

$3.04 Million

Previous $4.04 Million 19.45%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$2.7 - $4.01 $1.83 Million - $2.72 Million	678,020 Added 61.06%	1,788,500 $4.83 Million
Q2 2025 Aug 14, 2025	BUY	$1.55 - $3.97 $974,283 - $2.5 Million	628,570 Added 130.43%	1,110,480 $4.04 Million
Q1 2025 May 15, 2025	SELL	$1.69 - $2.84 $104,790 - $176,097	-62,006 Reduced 11.4%	481,910 $925,000
Q4 2024 Feb 14, 2025	BUY	$1.26 - $2.13 $370,872 - $626,950	294,343 Added 117.94%	543,916 $1.01 Million
Q3 2024 Nov 14, 2024	BUY	$0.94 - $1.55 $21,083 - $34,764	22,429 Added 9.87%	249,573 $329,000

Q2 2024 Aug 14, 2024	SELL	$0.86 - $1.63 $110,348 - $209,148	-128,312 Reduced 36.1%	227,144 $231,000
Q1 2024 May 15, 2024	BUY	$1.27 - $2.24 $168,448 - $297,106	132,637 Added 59.53%	355,456 $650,000
Q4 2023 Feb 14, 2024	BUY	$0.8 - $1.28 $96,232 - $153,972	120,291 Added 117.33%	222,819 $276,000
Q2 2023 Aug 14, 2023	SELL	$0.51 - $1.43 $46,374 - $130,031	-90,931 Reduced 47.0%	102,528 $94,000
Q1 2023 May 12, 2023	BUY	$0.56 - $1.15 $33,429 - $68,649	59,695 Added 44.63%	193,459 $108,000
Q4 2022 Feb 10, 2023	SELL	$0.25 - $0.58 $36,985 - $85,806	-147,942 Reduced 52.52%	133,764 $77,000
Q3 2022 Nov 14, 2022	SELL	$0.3 - $0.46 $55,014 - $84,355	-183,382 Reduced 39.43%	281,706 $90,000
Q2 2022 Aug 12, 2022	BUY	$0.32 - $0.67 $19,467 - $40,759	60,835 Added 15.05%	465,088 $162,000
Q1 2022 May 16, 2022	SELL	$0.72 - $2.93 $39,474 - $160,640	-54,826 Reduced 11.94%	404,253 $290,000
Q4 2021 Feb 08, 2022	BUY	$2.26 - $3.34 $679,511 - $1 Million	300,669 Added 189.8%	459,079 $1.04 Million
Q3 2021 Nov 15, 2021	BUY	$2.35 - $3.88 $168,878 - $278,828	71,863 Added 83.03%	158,410 $456,000
Q2 2021 Sep 13, 2021	BUY	$2.83 - $4.2 $244,928 - $363,497	86,547 New	86,547 $328,000

Others Institutions Holding AKBA

# of Institutions

189

Shares Held

121M

Call Options Held

267K

Put Options Held

280K

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $313M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Akebia Therapeutics, Inc. Transaction History